CJ
Insider
Charles A Rowland Jr
DirectorCharles A Rowland Jr (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Viking Therapeutics, Inc. (VKTX). The largest single filing was $2.1M of VKTX (60,000 sh × $35.57, as filed), executed Oct 27 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.1M
shares × price, as filed
Last traded
Oct 27 2025
Filed Oct 28 2025
Median ADV $77.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
VKTXRecent filings
VKTXSALE
Viking Therapeutics, Inc.
View filing →
$2.1M60,000 sh × $35.57
Exec Oct 27 2025
Filed Oct 28 2025 · 5:30 PM ET